–Topline efficacy data expected in Q4 2023 – – Preparations are underway to scale the CYB003 program to a potential...
According to Morningstar's recently-released Biopharma Pipeline Report, the biopharma industry can anticipate a healthy 4.5% in compound annual earnings...
In the current digital landscape, the impact of social media on youth mental health is becoming an increasingly pressing concern. Dr. Vivek Murthy,...
What You Should Know: Today, Anumana, a nference portfolio company working in collaboration with Mayo Clinic, announced it has received its first 510(k)...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE:7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development...
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,... The post Glancy Prongay...
If you have a baby today in the United States, the most dangerous place for your baby in terms of health and safety, is in the...
CraniUS, a medtech company based in Baltimore, has developed the NeuroPASS drug delivery system. The technology is designed to deliver drugs to the brain,...
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,... The post Glancy Prongay...